GARRY SILVESTI: Open Payments
NPI 1942248075 · LINWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,308 in 99 payments from 15 companies in 2025. Trend: 2023 $820 · 2024 $904 · 2025 $1,308
Food & beverage: $1,308
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 28 | $460 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 42 | $301 |
| SCILEX PHARMACEUTICALS INC. | 7 | $116 |
| ABBVIE INC. | 5 | $79 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $75 |
| Globus Medical, Inc. | 2 | $65 |
| BIOTRONIK NRO, Inc. | 2 | $38 |
| Azurity Pharmaceuticals, Inc. | 2 | $32 |
| Valinor Pharma, LLC | 2 | $29 |
| Abbott Laboratories | 1 | $22 |
Products named: Belbuca, RELISTOR, UBRELVY, JOURNAVX, Senza, ELYXYB - CELECOXIB, ZTLido, HORIZANT.
Industry payments across NJ — which companies pay providers there.
